Associations of Patella Lead and Other Lead Biomarkers With Renal Function in Lead Workers

Objective: We sought to compare associations of patella lead, which may represent a unique cumulative and bioavailable lead pool, with other lead measures in models of renal function. Methods: Renal function measures included blood urea nitrogen, serum creatinine, measured and calculated creatinine clearances, and urinary N-acetyl-β-D-glucosaminidase (NAG) and retinol-binding protein. Results: In 652 lead workers, mean (SD) blood, patella, and tibia lead were 30.9 (16.7) &mgr;g/dL, 75.1 (101.1) and 33.6 (43.4) &mgr;g Pb/g bone mineral, respectively, and were correlated (Spearman's r = 0.51–0.74). Patella lead was associated (P < 0.05) with NAG in all lead workers. In models of effect modification by age, higher patella lead also was associated with higher serum creatinine in older participants. Similar associations were observed for blood and tibia lead. Conclusions: Associations between patella lead and adverse renal outcomes were not unique; this may be due, in part, to high correlations among the lead biomarkers in this study.

[1]  Malik Beshir Malik,et al.  Applied Linear Regression , 2005, Technometrics.

[2]  W. Stewart,et al.  Associations of lead biomarkers with renal function in Korean lead workers , 2003, Occupational and environmental medicine.

[3]  J. Schwartz,et al.  A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study. , 2002, Environmental health perspectives.

[4]  W. Stewart,et al.  Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. , 2001, American journal of epidemiology.

[5]  P. Parsons,et al.  Electrothermal atomization atomic absorption spectrometry for the determination of lead in urine: results of an interlaboratory study , 1999 .

[6]  A. Todd.  Calculating bone-lead measurement variance. , 1999, Environmental health perspectives.

[7]  Howard Hu,et al.  Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. , 1998, Environmental health perspectives.

[8]  A. Rotnitzky,et al.  K X-ray fluorescence measurements of bone lead concentration: the analysis of low-level data , 1995, Physics in medicine and biology.

[9]  D. Bradley,et al.  Renal function and hyperfiltration capacity in lead smelter workers with high bone lead. , 1994, Occupational and environmental medicine.

[10]  A C Todd,et al.  In vivo X-ray fluorescence of lead in bone: review and current issues. , 1994, Environmental health perspectives.

[11]  H. Gonick,et al.  Experimental model of lead nephropathy. III. Continuous low-level lead administration. , 1993, Archives of environmental health.

[12]  R Attewell,et al.  In vivo measurements of lead in bone in long-term exposed lead smelter workers. , 1993, Archives of environmental health.

[13]  R. Alinovi,et al.  Experimental model of lead nephropathy. I. Continuous high-dose lead administration. , 1992, Kidney international.

[14]  A. Todd,et al.  Kidney effects in long term exposed lead smelter workers. , 1992, British journal of industrial medicine.

[15]  C. Dolman,et al.  Measurement of urinary retinol-binding protein by enzyme-linked immunosorbent assay, and its application to detection of tubular proteinuria. , 1986, Clinical chemistry.

[16]  W. Cleveland.  Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .

[17]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[18]  F J Fernandez,et al.  Micromethod for lead determination in whole blood by atomic absorption, with use of the graphite furnace. , 1975, Clinical chemistry.

[19]  A. Todd.  Contamination of in vivo bone-lead measurements. , 2000, Physics in medicine and biology.

[20]  F. McNeill,et al.  In vivo measurements of lead in bone using a 109Cd 'spot' source. , 1993, Basic life sciences.

[21]  Ruddle Fh,et al.  Human gene mapping 3. Baltimore Conference (1975). Third International Workshop on Human Gene Mapping. Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6. , 1976, Cytogenetics and cell genetics.